Diagnosis

AI app reveals your biological age – and how to slow it down

Only as old as you feel ... or only as old as your Young.AI app tells you? We use our phones for just about everything...

Insilico teams-up with Intel to identify disease progression risk

Insilico's new COVIDomic platform combines cutting-edge AI with Intel Xeon processors and could turn the pandemic tide. Insilico have been rather busy lately; a couple...

Machine learning unlocks the complexities of multimorbidity

New paper reviews how machine learning can support multimorbidity research to promote Longevity. Longevity research has been able to leverage the power of machine learning...

Inside is the new outside for DNA and PT collaboration

Working your core means going even deeper - right down to your genes - thanks to PT Hub and Muhdo Health. Biohacking – DIY Biology...

Microbiome clock has the guts to tell your age

Insilico and Harvard develop the first AI-powered microbiomic aging clock. Scientists from Harvard Medical School and Insilico Medicine have used thousands of whole genome sequencing samples...

New benchmark for senescence developed from CellAge database

Comprehensive cellular senescence database will provide benchmark for the development of senolytic therapies. Our cells are intrinsically programmed for senescence – a gradual aging and...

Longevity and the Singularity

Consciousness in the cloud? Where science fact and fiction collide. While the principle focus of Longevity is undoubtedly the extension of healthy human lifespan, there...

Longevity2020: Day 3 recap

Experts, innovators, investors and the curious meet online in the biggest Longevity conference ever staged. As we enter the fourth day of Longevity2020, we thought...

Margaretta Colangelo on Longevity2020

An in-depth preview of big-hitting AI speakers at the first ever online Longevity conference. It's finally here - Longevity2020 week has arrived! Later today, we...

AI, COVID-19 and aging: this time it’s personal

Dr Richard Siow talks COVID-19, its implications for Longevity, and how AI can play a role. Scientists across the world are scrambling in response to...

Call for consensus in defining biological aging

We speak with a key contributor to the Longevity2020 online conference about biological aging. UK start-up AgeCurve is focused on the measurement of aging and...

VR for brain training and tracking cognitive health

Virtuleap currently fundraising to build headcount and capitalise on cognitive illness detection algorithms. Ever since the US Federal Trade Commission fined Lumosity $2 million for...

Detecting atrial fibrillation through a phone

Researchers in Hong Kong have developed a tool which could hold another key to promoting Longevity. Researchers in Hong Kong have developed a tool that...

Artificial intelligence: It’s about TIME

In the second of our two-part look at the Longevity implications of TIME's 2019 Best Inventions list (following Agetech), we take a look at the...

AI biomarker built to measure brain age

University of Oslo researchers develop AI biomarker for tracking neurological treatment over time. Finding timely therapies for age begins with finding a way to measure...

AI tool detects heart failure from a single heartbeat

Researchers develop a neural diagnostic tool which can detect cardiac anomalies with 100% accuracy Artificial intelligence (AI) has now taken another step forward in healthcare,...

Boris allocates £250m to NHS for AI

Pledge to use artificial intelligence to speed up diagnosis - but can the NHS keep-pace with AI recruitment costs? In its third pledge to the...

FDA approves Qclarity as first ever breast-cancer diagnostic AI

Qclarity, produced by Paragon Biosciences, looks to improve the quality and speed of breast cancer diagnoses. About 30 million women are screened for breast cancer...

Amprion’s test a game-changer for Parkinson’s

FDA grants “Breakthrough Device” designation to Amprion's new technology as it is fast-tracked to market. Parkinson's is a debilitating chronic, progressive neurodegenerative disease that is...

Longevity fund joins $160m round in Freenome

Longevity Vision fund announced today that they are investing in Freenome, a California-based firm that is developing "simple but very accurate blood tests ". Longevity.Technology:...

Latest articles

Big Brother approach to accelerate preclinical studies

Tracked.bio develops AI computer vision system that tracks flies and mice to reduce man-hours and increase data collected in Longevity studies. A Danish start-up aims...

Deliver us from aging – the Quicksilver method

Bigger certainly doesn't mean better when it comes to Quicksilver's nutraceutical delivery methods. The COVID-19 pandemic has caused an upturn in the supplements industry; from...

Astellas to acquire iota Biosciences

Following an R&D collaboration that began last year, Japanese pharma Astellas has announced it will acquire bioelectronics firm iota in $304m deal. Last year's R&D...

OneSkin launches topical senetherapeutic skin treatment

Extending skinspan with non-invasive senetherapeutic proprietary peptide. OneSkin is a Longevity company on a mission to transform the way we think about skin. Today the...